AMGEN INC
For the period ended Mar 31, 2025. Filed May 2, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 2, 2025
AMGN$465.230.0%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
CONDENSED CONSOLIDATED STATEMENTS OF INCOME (LOSS)
| Three months endedMarch 31, | ||
|---|---|---|
| 2025 | 2024 | |
| Revenues: | ||
| Product sales | $7,873 | $7,118 |
| Other revenues | 276 | 329 |
| Total revenues | 8,149 | 7,447 |
| Operating expenses: | ||
| Cost of sales | 2,968 | 3,200 |
| Research and development | 1,486 | 1,343 |
| Selling, general and administrative | 1,687 | 1,808 |
| Other | 830 | 105 |
| Total operating expenses | 6,971 | 6,456 |
| Operating income | 1,178 | 991 |
| Other income (expense): | ||
| Interest expense, net | (723) | (824) |
| Other income (expense), net | 1,518 | (235) |
| Income (loss) before income taxes | 1,973 | (68) |
| Provision for income taxes | 243 | 45 |
| Net income (loss) | $1,730 | $(113) |
| Earnings (loss) per share: | ||
| Basic | $3.22 | $(0.21) |
| Diluted | $3.20 | $(0.21) |
| Weighted-average shares used in calculation of earnings (loss) per share: | ||
| Basic | 538 | 536 |
| Diluted | 541 | 536 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.